Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Short Candidates -- Ignore unavailable to you. Want to Upgrade?

To: opalapril who wrote (4)	1/9/2001 11:27:32 AM
From: tuck	Read Replies (1) \| Respond to of 897

opalapril, Thanks for disposing of that one so quickly. OK, I'll try to jump start this. How about the genomics companies with an excessive reliance on their patent estate? CRA and HGSI (which I've seen mentioned on Auric's thread) come to mind. INCY, by comparison, uses its IP differently, and seems a screaming bargain to me now. Various SNP companies seem like plausible candidates. No clear winner in that space. Any obvious losers that haven't already been priced as such? Maybe CALP? WAT? And CLPA has recovered somewhat to 6. Could be good for a 40% reversal. Cheers, Tuck